The bumpy road to achieve herd immunity in COVID-19

Area of Science:

• Epidemiology
• Immunology
• Public Health

Background:

• Herd immunity provides indirect protection against infectious diseases when a large community proportion is immune.
• Immunity can be acquired through vaccination or natural recovery from illness.
• Achieving herd immunity for SARS-CoV-2 presents unique challenges.

Purpose of the Study:

• To elaborate on the hurdles encountered in developing herd immunity to SARS-CoV-2 infection.
• To discuss the complexities of achieving and maintaining herd immunity in a global pandemic context.

Main Methods:

• Review and analysis of existing literature on herd immunity and SARS-CoV-2.
• Discussion of epidemiological factors influencing herd immunity thresholds.
• Examination of immunological and virological aspects impacting immune response duration and stability.

Main Results:

• Herd immunity for SARS-CoV-2 is difficult to achieve uniformly across diverse geographical areas due to variations in population density and control measures.
• A high proportion of population immunization (50-66%) is required, which is challenging to attain.
• Factors such as the duration of immunity, epitope stability, and viral mutations pose significant obstacles.

Conclusions:

• Developing effective herd immunity strategies for SARS-CoV-2 requires addressing multiple complex hurdles.
• Societal tactics must be carefully designed, considering population welfare and the dynamic nature of the virus.
• Further research is needed on long-term immune responses and viral evolution to inform public health interventions.